ALXN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Alexion Pharmaceuticals Inc's quarterly accounts payable declined from Dec. 2014 ($439 Mil) to Mar. 2015 ($361 Mil) but then increased from Mar. 2015 ($361 Mil) to Jun. 2015 ($454 Mil).
Alexion Pharmaceuticals Inc's annual accounts payable increased from Dec. 2012 ($228 Mil) to Dec. 2013 ($424 Mil) and increased from Dec. 2013 ($424 Mil) to Dec. 2014 ($439 Mil).
Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.
It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Alexion Pharmaceuticals Inc Annual Data
Alexion Pharmaceuticals Inc Quarterly Data